•Intestinal flagellin drives multisystem inflammation through TLR5-IL-15-ARA axis
•Regional fat distribution as a novel predictor of fracture risk in inflammatory bowel disease: a DXA-based cohort study
•Outcomes of risankizumab use in adults with Crohn's disease in a real-world setting (ARISE-CD): a multicentre, retrospective cohort study
•Biomaterial-Based Microbiota Strategies for Targeting the Intestinal Immune Microenvironment in Inflammatory Bowel Disease
•Synergistic efficacy of inulin gel capsulated metal-phenolic networks: Treating colitis and depression by regulating AKK and gut-brain axis
